Funding Opportunities

The Pharmacoepidemiology program has benefited from the generous unrestricted support of its corporate partners, including Pfizer, Novartis, ASISA and other major pharmaceutical companies. These partners have enabled the Harvard School of Public Health to provide full tuition support to several doctoral students annually since the Program’s inception in 1986.